Hypertension (HTN) increases the risk of development of HF and it precedes it in 75% of cases. HF patients are nearly evenly divided between those with reduced left ventricular (LV) function or ...

RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has reached a significant milestone in its Advance-HTN trial by hitting its enrollment target of 261 participants. This pivotal trial is ...

FRIDAY, Sept. 13, 2024 (HealthDay News) -- Predictive models for hypertension screening have been developed using speech recordings, with accuracies up to 84 percent for women and 77 percent for ...

Tech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, ...

SCRATCH-HTN aims to explore a new way of managing high blood pressure (BP), specifically in people who have raised BP despite being on antihypertensive medications. Participants will use an external ...

A new study published in the European Heart Journal showed that semaglutide is a helpful additional medication for the ...

Emerging evidence suggests a link between salivary metabolite changes and neurodegenerative dementia, with antimicrobial peptides (AMPs) implicated in its pathogenesis.We investigated the effects of a ...

GIRLS ——————– Team standings — 1. Houghton 18, 2. Negaunee 68, 3. Hancock 82, 4. Calumet 84, 5. Westwood 101. Ishpeming, Gwinn and West Iron County, no team scores ——————– Top finishers — 1. Tessa ...

Virtual KOL event scheduled on October 30th to discuss the unmet need in hypertension, as well as a review of the ongoing pivotal clinical program for lorundrostat in hypertension – RADNOR, Pa., Sept.